Increasing Decision Quality for Men With Lower Urinary Tract Symptoms

NCT ID: NCT04851275

Last Updated: 2021-04-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-04-15

Study Completion Date

2020-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, the investigators show that by upskilling of primary care physicians (PCPs) in SDM and leveraging on a novel pictorial Visual Analogue Uroflowmetry Score (VAUS), they can enhance older men's recognition of LUTS and stimulated discussion with their PCPs.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Lower urinary tract symptoms (LUTS), often related to prostatomegaly, is common but seldom sought medical attention amongst older men. Visual-aid and shared decision-making (SDM) are potential solutions to address LUTS. The study aimed to determine the effect of a novel pictorial Visual Analogue Uroflowmetry Score (VAUS) and primary care physicians (PCP) SDM training on the decisional quality amongst men selecting their treatment options for LUTS.

This study recruited 60 multi-ethnic Asian men aged ≥50 years with moderate-to-severe LUTS (International Prostate Symptoms Score≥8 and/or QOL≥3) in a Singapore public primary care clinic. Men used the VAUS to report their symptoms. 60 men were randomly assigned to PCPs trained in SDM in the intervention group (n=30) and the other 30 to the control group (PCPs without SDM-training). Patient-physician dyad decision quality was measured using the validated SDMQ-9 (patient) and SDMQ-Doc (physician) questionnaires.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Patient Engagement Patient Preference

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Shared decision making for men with lower urinary tract symptoms

Participants used the Visual Analogue Uroflowmetry Score so report their symptoms and were attended by Primary Care Physicians trained in shared decision making

Group Type EXPERIMENTAL

Physicians trained in shared decision making

Intervention Type BEHAVIORAL

Physicians in this group were trained in shared decision making

No shared decision making for men with lower urinary tract symptoms

Participants did not use the Visual Analogue Uroflowmetry Score to report their symptoms and received usual care by Primary Care Physicians not trained in shared decision making

Group Type ACTIVE_COMPARATOR

Physicians were not trained in shared decision making

Intervention Type BEHAVIORAL

Physicians did not receive training in shared decision making

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Physicians trained in shared decision making

Physicians in this group were trained in shared decision making

Intervention Type BEHAVIORAL

Physicians were not trained in shared decision making

Physicians did not receive training in shared decision making

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* men aged 50 years old and older attending the polyclinic for routine follow up of a chronic disease (non-communicable disease)
* have moderate-to-severe LUTS and/or poor quality of life (QOL) as assessed by the validated International Prostate Symptom Score (IPSS) of eight or more and/or its individual QOL score of three or more
* men of any local Asian ethnicity and were willing to provide written consent
* can communicate with their allocated PCP in either of the three main local languages; English, Mandarin or Malay.

Exclusion Criteria

* have indwelling catheters
* urinary incontinence requiring diapers
* anuria due to any renal pathology
* gross hematuria
* acute urinary retention
* symptoms consistent with an acute urinary tract infection
* existing treatment of LUTS or other prostate pathology
* visual or hearing impairment which render men incapable of understanding the study procedure and providing informed consent
* men unwilling to discuss their LUTS treatment options with their PCP
Minimum Eligible Age

50 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Singapore General Hospital

OTHER

Sponsor Role collaborator

SingHealth Polyclinics

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tan Ngiap Chuan, MBBS

Role: STUDY_DIRECTOR

Singhealth polyclinic

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Haidee Ngu

Singapore, , Singapore

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Singapore

References

Explore related publications, articles, or registry entries linked to this study.

Tiwari R, Ng MY, Neo SH, Mangat R, Ho H. Prospective validation of a novel visual analogue uroflowmetry score (VAUS) in 1000 men with lower urinary tract symptoms (LUTS). World J Urol. 2020 May;38(5):1267-1273. doi: 10.1007/s00345-019-02909-1. Epub 2019 Aug 27.

Reference Type BACKGROUND
PMID: 31451932 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2018/3106

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.